IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 141 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,026,346 | -8.7% | 2,643,155 | +41.3% | 0.01% | 0.0% |
| Q2 2023 | $13,166,562 | +12.7% | 1,870,250 | -2.2% | 0.01% | +12.5% |
| Q1 2023 | $11,687,037 | +77.3% | 1,912,772 | +85.4% | 0.01% | +60.0% |
| Q4 2022 | $6,591,867 | -35.5% | 1,031,591 | -3.4% | 0.01% | -37.5% |
| Q3 2022 | $10,226,000 | +1.0% | 1,067,432 | +16.4% | 0.01% | +14.3% |
| Q2 2022 | $10,120,000 | +7.3% | 916,683 | +61.8% | 0.01% | +16.7% |
| Q1 2022 | $9,435,000 | -12.0% | 566,658 | +0.9% | 0.01% | 0.0% |
| Q4 2021 | $10,721,000 | -20.5% | 561,587 | +2.7% | 0.01% | -33.3% |
| Q3 2021 | $13,486,000 | -1.3% | 546,867 | +4.1% | 0.01% | 0.0% |
| Q2 2021 | $13,663,000 | +3.0% | 525,083 | +25.4% | 0.01% | 0.0% |
| Q1 2021 | $13,261,000 | -25.1% | 418,872 | +9.8% | 0.01% | -30.8% |
| Q4 2020 | $17,699,000 | +45.0% | 381,453 | +2.9% | 0.01% | +30.0% |
| Q3 2020 | $12,202,000 | +20.2% | 370,674 | +0.2% | 0.01% | +11.1% |
| Q2 2020 | $10,152,000 | +77.5% | 369,868 | +93.5% | 0.01% | +50.0% |
| Q1 2020 | $5,721,000 | +102.2% | 191,108 | +86.9% | 0.01% | +200.0% |
| Q4 2019 | $2,830,000 | +324.9% | 102,250 | +179.3% | 0.00% | +100.0% |
| Q3 2019 | $666,000 | -18.5% | 36,615 | +9.9% | 0.00% | 0.0% |
| Q2 2019 | $817,000 | +193.9% | 33,312 | +14.0% | 0.00% | – |
| Q1 2019 | $278,000 | +26.4% | 29,217 | +17.4% | 0.00% | – |
| Q4 2018 | $220,000 | -33.1% | 24,897 | -14.8% | 0.00% | – |
| Q3 2018 | $329,000 | +2.2% | 29,234 | +16.3% | 0.00% | – |
| Q2 2018 | $322,000 | – | 25,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |